Magnesium 2 g Infusion Rate
Administer 2 g of magnesium sulfate intravenously over 15 minutes for most acute indications, including torsades de pointes and polymorphic ventricular tachycardia with QT prolongation. 1
Evidence-Based Infusion Rates by Clinical Context
Cardiac Arrhythmias (Torsades de Pointes)
The 2010 AHA ACLS Guidelines establish the standard for magnesium administration in life-threatening arrhythmias:
- 1 to 2 g IV over 15 minutes for polymorphic VT associated with QT prolongation (torsades de pointes) 1
- For pulseless torsades, give as a bolus 2
- For torsades with pulses, infuse over 10-20 minutes 2
The 2004 ACC/AHA STEMI Guidelines similarly recommend 1 to 2 g as an intravenous bolus over 5 minutes for torsades-type VT 3. The 2010 AHA statement on torsades prevention specifies 2 g can be infused intravenously and may require repeated doses 4.
Hypomagnesemia in Pediatrics
For pediatric patients with hypomagnesemia or torsades:
- 25-50 mg/kg (maximum 2 g) over 10-20 minutes for hypomagnesemia/torsades with pulses 2
- Over 15-30 minutes for refractory status asthmaticus 2
FDA-Approved Labeling
The FDA label provides general guidance that the rate of IV injection should generally not exceed 150 mg/minute (1.5 mL of a 10% concentration), except in severe eclampsia with seizures 5. This translates to approximately 13-14 minutes for a 2 g dose under routine circumstances.
Clinical Rationale
Rapid infusion may cause hypotension and bradycardia 2, which is why the 15-minute timeframe represents a balance between therapeutic urgency and safety. The mechanism involves:
- Vasodilation leading to hypotension
- Direct effects on cardiac conduction
- CNS toxicity and respiratory depression at toxic levels 1
Have calcium chloride available to reverse magnesium toxicity if needed 2.
Context-Specific Modifications
When to Infuse More Slowly
- Hypomagnesemia without arrhythmia: Consider slower infusion over 10-20 minutes 2
- Renal insufficiency: Exercise greater caution; monitor serum levels closely 1
- Hemodynamically unstable patients: Balance speed against risk of further hypotension
When Bolus Administration is Appropriate
- Cardiac arrest with pulseless torsades: Give as rapid IV/IO bolus 2, 1
- Severe eclampsia with active seizures: May exceed standard rate per FDA labeling 5
Safety Monitoring
During and immediately after infusion, monitor:
- Blood pressure (watch for hypotension)
- Heart rate (watch for bradycardia)
- Respiratory rate (depression occurs at high serum levels)
- Deep tendon reflexes (loss indicates impending toxicity at 3.5-5 mmol/L)
Therapeutic range: 1.8-3.0 mmol/L for eclamptic convulsions 6
Toxicity warning signs: Loss of patellar reflex (3.5-5 mmol/L), respiratory paralysis (5-6.5 mmol/L), cardiac arrest (>12.5 mmol/L) 6
Common Pitfalls
- Infusing too slowly in emergent arrhythmias: The 15-minute standard exists for a reason—slower infusion may delay therapeutic effect when treating life-threatening torsades
- Forgetting to dilute: Solutions for IV infusion must be diluted to 20% concentration or less 5
- Inadequate monitoring: Hypotension and bradycardia can develop during infusion; continuous monitoring is essential
- Ignoring renal function: Magnesium is renally excreted; adjust dosing and increase monitoring frequency in renal insufficiency 1